ViTToria Biotherapeutics

Philadelphia, PA · Founded 2021 · Privately Held (backing)

Operator of a T-cell therapeutics company intended to offer a therapeutic pipeline targeting clinical needs in oncology and autoimmune disease. ViTToria Biotherapeutics is based in Philadelphia, PA and was founded in 2021. It was valued at $30 million at its early-stage round in Nov 2024, the last priced event on record. It has raised $49.9 million across 1 recorded round; the latest was an $8.7 million early-stage round in Jul 2021.

PMV mark · valuation
$30.0M
Oct 2026
Priced at
its early-stage round
Nov 2024
Total raised
$49.9M
Last round
Early Stage VC
Jul 2021
What is ViTToria Biotherapeutics worth?
$30.0MPrivateMarketView mark · Oct 2026

Valued at $30.0M at its early-stage round, Nov 2024. Nothing has traded since.

Free account
More of ViTToria Biotherapeutics with a free account
  • ·The complete investor list: 15 names
  • ·Watch ViTToria Biotherapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

ViTToria Biotherapeutics funding history

1 rounds
DateRoundRaisedPost-money
Jul 2021Early Stage VC$8.7M▮
Unlock post-money valuations

Membership and data by Private Market View

ViTToria Biotherapeutics valuation

ViTToria Biotherapeutics was valued at $30 million at its early-stage round in Nov 2024. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has ViTToria Biotherapeutics raised?

ViTToria Biotherapeutics has raised $49.9 million in total; 1 of its rounds is on record. The largest on record was an $8.7 million early-stage round in Jul 2021.

ViTToria Biotherapeutics has filed 1 Form D with the SEC, most recently in Dec 2021 ($8.7 million sold to 11 investors).

How ViTToria Biotherapeutics's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For ViTToria Biotherapeutics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about ViTToria Biotherapeutics

What is ViTToria Biotherapeutics worth?
ViTToria Biotherapeutics is valued at $30.0M as of Oct 2026. Valued at $30.0M at its early-stage round, Nov 2024. Nothing has traded since.
How much has ViTToria Biotherapeutics raised?
ViTToria Biotherapeutics has raised $49.9M in total funding across 1 recorded rounds.
When did ViTToria Biotherapeutics last raise?
ViTToria Biotherapeutics last raised in Jul 2021 (Early Stage VC), raising $8.7M.